Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8210589 | International Journal of Radiation Oncology*Biology*Physics | 2018 | 9 Pages |
Abstract
In patients with untreated oropharyngeal SCCHN, HPV-associated tumors displayed the highest levels of PD-L1 expression and PD-1+ and CD8+ immune cells. Locally recurrent tumors had lower levels of PD-L1, PD-1, and CD-8 positivity. Whereas almost all SCCHN tumors had CD56+ infiltrating natural killer cells, most tumors didn't have PD-L2 expression. These associations may help predict which patients may benefit most from immunotherapeutic approaches.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Jonathan D. MD, MPhil, MPH, Evisa PhD, Scott J. MD, PhD, Roy B. MD, PhD, Bhupendra MS, Paul J. ScD, Ravindra MD, PhD, Robert I. MD, Glenn J. MD, Nicole G. MD, Guilherme MD, Jochen MD, Vickie Y. MD, Jeffrey F. MD, PhD, Laura A. MD, Donald J. MD, Sara MS,